Moscow, Moscow, Russian Federation
Moscow, Moscow, Russian Federation
Moscow, Moscow, Russian Federation
Moscow, Moscow, Russian Federation
Moscow, Moscow, Russian Federation
Moscow, Moscow, Russian Federation
Stavropol, Stavropol, Russian Federation
Stavropol, Russian Federation
UDK 616.31 Стоматология. Заболевания ротовой полости и зубов
Clinical and laboratory studies were conducted in 24 patients with chronic dental periimplantitis before and after complex treatment aimed at destroying biofilms on the surface of the dental implant to prevent indirect infection. The aim of the study is to develop a comprehensive, etiologically based treatment regimen for dental peri-implantitis based on correction of the oral microbiota. The study was based on indicators of secretory immunoglobulin A (IgA) and an analysis of the composition of the microbiome of mixed saliva in patients with healthy implants and peri-implantitis. A new conceptual approach to the diagnosis and pathogenetically based comprehensive treatment of dental peri-implantitis is proposed. At the first stage, a peri-implantitis treatment regimen was performed according to the protocol “The EFP S3 level clinical practice guideline”. After performing this standard treatment for 6 weeks, we have proposed a scheme that includes: 1) the drug for inhibiting the bacterial film “ACC LONG” 600 mg (Hermes Pharma, Germany) – in the form of oral baths for 2 minutes 30 minutes before meals; 2) for the purpose of adhesion and sorption of biofilm elements – Chitosan succinate (Active+ drug, GREEN VOICE, Russia) after meals in rinsing method: dosage of 10–12 drops per 250 ml of liquid; 3) for the purpose of probiotic correction of oral microbiocenosis, the drug BIFIDUM BAG (5 ml dissolved in water no higher than 40 °C) for 20–30 minutes topically in the form of mouth baths, then swallow after eating for one month. It was found that with the progression of peri-implantitis, there is a decrease in the level of secretory IgA and a decrease in local resistance of the oral cavity to pathogenic influences. The standard treatment regimen helps to stabilize inflammation in the area of dental implants, but does not lead to a sustained positive effect.
dental peri-implantitis, treatment of peri-implantitis, chitosan complex, secretory IgA, dysbiosis of the oral cavity
1. Herrera D., Berglundh T., Schwarz F., Chapple I., Jepsen S., Sculean A., Kebschull M., Papapanou P.N., Tonetti M.S., Sanz M. EFP workshop participants and methodological consultant. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline // J Clin Periodontol. – 2023;50(26):4-76. doi:https://doi.org/10.1111/jcpe.13823.
2. Yin Q., Liang J., Zhang Y. et al. Critical review on quality of methodology and recommendations of clinical practice guidelines for peri-implantitis // BMC Oral Health. – 2023;23:189. https://doi.org/10.1186/s12903-023-02904-4
3. Romandini M., Lima C., Pedrinaci I., Araoz A., Soldini M.C., Sanz M. Prevalence and risk/protective indicators of peri-implant diseases: A university-representative cross-sectional study // Clin Oral Implants Res. – 2021;32(1):112-122. doihttps://doi.org/10.1111/clr.13684
4. Wada M., Mameno T., Otsuki M., Kani M., Tsujioka Y., Ikebe K. Prevalence and risk indicators for peri-implant diseases: A literature review // Jpn Dent Sci Rev. – 2021;57:78-84. doihttps://doi.org/10.1016/j.jdsr.2021.05.002
5. Chambrone L., Wang H.L., Romanos G.E. Antimicrobial photodynamic therapy for the treatment of periodontitis and peri-implantitis: An American Academy of Periodontology best evidence review // J Periodontol. – 2018;89(7):783-803. doihttps://doi.org/10.1902/jop.2017.170172
6. Renvert S., Hirooka H., Polyzois I., Kelekis-Cholakis A., Wang H.L. Diagnosis and non-surgical treatment of peri-implant diseases and maintenance care of patients with dental implants - Consensus report of working group 3 // Int Dent J. – 2019;69(2):12-17. doi:https://doi.org/10.1111/idj.12490.
7. Nicholls J. The management of periodontal and peri implant disease // BDJ Team. – 2020;7:34-36. https://doi.org/10.1038/s41407-020-0346-5
8. Roccuzzo M., Mirra D., Pittoni D., Ramieri G., Roccuzzo A. Reconstructive treatment of peri-implantitis infrabony defects of various configurations: 5-year survival and success // Clin Oral Implants Res. – 2021;32(10):1209-1217. doihttps://doi.org/10.1111/clr.13818
9. Kadkhodazadeh M., Amid R., Moscowchi A. Does COVID-19 Affect Periodontal and Peri-Implant Diseases? // J Long Term Eff Med Implants. – 2020;30(1):1-2. doihttps://doi.org/10.1615/JLongTermEffMedImplants.2020034882
10. Veerachamy S., Yarlagadda T., Manivasagam G., Yarlagadda P.K. Bacterial adherence and biofilm formation on medical implants: a review // Proc Inst Mech Eng H. – 2014;228(10):1083-1099. doihttps://doi.org/10.1177/0954411914556137
11. Corsalini M., Montagnani M., Charitos I.A., Bottalico L., Barile G., Santacroce L. Non-Surgical Therapy and Oral Microbiota Features in Peri-Implant Complications: A Brief Narrative Review // Healthcare (Basel). – 2023;11(5):652. doihttps://doi.org/10.3390/healthcare11050652
12. Kensara A., Saito H., Mongodin E.F., Masri R. Microbiological profile of peri-implantitis: Analyses of microbiome within dental implants // J Prosthodont. – 2023;32(9):783-792. doihttps://doi.org/10.1111/jopr.13653
13. Kornienko E.A. Metabolic activities of microbiota and metabiotics // RMJ. – 2016;18:1196-1201. https://www.rmj.ru/articles/pediatriya/Metabolicheskoe_deystvie_mikrobioty_i_metabiotiki/
